Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Safety, Tolerance, Pharmacodynamics and Pharmacokinetics Study of Sobetirome in Male Subjects Diagnosed With X-linked Adrenoleukodystrophy (X-ALD)

NCT01787578 is registered in ClinicalTrials.gov with Thomas S. Scanlan as lead sponsor.

NCT NCT01787578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01787578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Safety, Tolerance, Pharmacodynamics and Pharmacokinetics Study of Sobetirome in Male Subjects Diagnosed With X-linked Adrenoleukodystrophy (X-ALD)
Lead sponsor
Thomas S. Scanlan
Phase
Phase 1
Overall status
Withdrawn
Start date
April 30, 2013
Completion date
February 28, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenomyeloneuropathy, x-linked adrenoleukodystrophy